Scripps 38th Annual New Treatments in Chronic Liver Disease 2024
$40.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Scripps 38th Annual New Treatments in Chronic Liver Disease 2024
Scripps 38th Annual New Treatments in Chronic Liver Disease 2024
- Include: 16 videos + 1 pdf, size: 2.23 GB
- Target Audience: hepatologists, gastroenterologists, infectious disease physician
- Sample video: contact me for sample video
Information:
Course Overview
This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.
Educational Objectives
After attending this live activity, participants should be able to:
• Assess new therapies for curing Delta Hepatitis and Hepatitis B.
• Review guidelines for the management of cholestatic liver diseases.
• Outline recent advances in the understanding and management of ascites and hepatorenal syndrome.
• Evaluate drugs in development for metabolic liver disease.
• Address causes and trends of liver disease and liver transplantation in women.
Target Audience
• Hepatologists
• Gastroenterologists
• Infectious Disease Specialists
Topics:
- brochure_for_web_liver24.pdf
- ESLD, HCC AND TRANSPLANTATION Advances in the Treatment of HCC.mp4
- ESLD, HCC AND TRANSPLANTATION Chronic Liver Disease and Liver Transplantation in Women.mp4
- ESLD, HCC AND TRANSPLANTATION Panel Discussion Q&A.mp4
- ESLD, HCC AND TRANSPLANTATION Update of AASLD Guidelines on Portal Hypertension.mp4
- ESLD, HCC AND TRANSPLANTATION WILLIAM S. HAUBRICH LECTURE- Renal Dysfunction in the Cirrhotic Patient.mp4
- EVOLVING THERAPIES FOR ADVANCED LIVER CARE Alcohol Liver Disease.mp4
- EVOLVING THERAPIES FOR ADVANCED LIVER CARE Cholestatic Liver Diseases.mp4
- EVOLVING THERAPIES FOR ADVANCED LIVER CARE Colocalization of Addiction Medicine.mp4
- EVOLVING THERAPIES FOR ADVANCED LIVER CARE Emerging Therapies for Delta Hepatitis and Hepatitis B.mp4
- EVOLVING THERAPIES FOR ADVANCED LIVER CARE Management of Liver Masses.mp4
- EVOLVING THERAPIES FOR ADVANCED LIVER CARE Panel Discussion Q&A.mp4
- IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Diversity in MASH.mp4
- IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Incretins for Metabolic Liver Disease.mp4
- IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE New Nomenclature for Steatotic Liver Disease .mp4
- IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Panel Discussion Q&A.mp4
- IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Selective Thyroid Hormone Receptor- Beta (TRá) Agonists for MASH.mp4
Related products
Critical Care - Emergency medicine
Internal Medicine
Anesthesiology & pain medicine
Internal Medicine
Anesthesiology & pain medicine
Critical Care - Emergency medicine
Critical Care - Emergency medicine
2022 UPDATES IN THERAPEUTICS: CRITICAL CARE PHARMACY PREPARATORY REVIEW AND RECERTIFICATION COURSE